Sanjay Kaul, MD, MPH
Articles
Reducing inflammatory biomarkers: What does it mean?
September 10th 2008The principal finding of this study is that among patients with type II diabetes and mixed dyslipidemia, treatment with simvastatin, fenofibrate, or their combination was associated with reductions in inflammatory biomarkers high-sensitivity C-reactive protein (hsCRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2).
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: October 9th 2014 | Updated: December 9th 2024
Widespread "Yellow Bumps"
Published: September 23rd 2014 | Updated: December 9th 2024
Itchy, Oozing Rash
Published: December 4th 2024 | Updated: December 9th 2024
Endoscopy in the Age of GLP-1 RAs: 2024 Sees New Risk-Based Perioperative Guidance
Published: December 3rd 2024 | Updated: December 9th 2024
This Year in Medicine 2024: Stories that Defined Healthcare
